Universal Vision Biotechnology Co

Universal Vision Biotechnology Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 1.57. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.54 — a change of 2.12% (higher).

PEG

1.57

YoY

2.12%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Universal Vision Biotechnology Co is 2025 1.57 . PEG Ratio (Price/Earnings-to-Growth) of Universal Vision Biotechnology Co was 2024 1.54 . It decreases by 2.12% higher compared to the previous year.

The Universal Vision Biotechnology Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
10.12 TWD
Jan 1, 2019
6.87 TWD
Jan 1, 2020
3.38 TWD
Jan 1, 2021
2.75 TWD
Jan 1, 2022
1.92 TWD
Jan 1, 2023
1.56 TWD
Jan 1, 2024
1.54 TWD
Jan 1, 2025
1.57 TWD
The Universal Vision Biotechnology Co PEG history
YEARPEGYoY
1.57+2.12%
1.54-1.84%
1.56-18.62%
1.92-29.99%
2.75-18.85%
3.38-50.75%
6.87-32.15%
10.12-25.63%
13.61-23.55%
17.80-11.69%
20.16+25.29%
16.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

PEG Ratio (Price/Earnings-to-Growth) of Universal Vision Biotechnology Co is 1.57 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Universal Vision Biotechnology Co changed from 1.54 to 1.57, representing a 2.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Universal Vision Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Universal Vision Biotechnology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Universal Vision Biotechnology Co